Fr
Contact us
Science
Cell Expansion
and Engineering Platform
ExCellThera’s robust cell expansion and engineering platform is based on three pillars of excellence.

The company’s technology platform is based on a pipeline of proprietary molecules with strong patent positions. Its know-how in cell manufacturing has made it a leader in effective and robust stem cell expansion. ExCellThera is also leveraging its cell engineering expertise to further optimize its platform.

Pipeline of Proprietary Molecules with Strong Patent Positions
UM171 Series
UM092 Series
Fr
Contact us
Science
Pipeline

Program

Cell Line

Ownership

Product

Discovery

Pre-Clinical

Phase I

Phase 2

Phase 3

HSCT

Cord Blood HSCs

ECT-001-CB

Mobilized Blood/
Bone Marrow HSCs

ECT-001-mPB

ECT-001-BM

Engineered HSCs
(eHSCs)

ECT-002

Solid Organ
Tolerization

Bone Marrow

HSCs

+ collaborators

iPSC

Pluripotent Stem

Cells (PSCs)

Out-licence
& supply

Gene Therapy

Transduced

HSCs

+ collaborators

HSCT

Cell Line

Ownership

Product

Cord Blood HSCs

ECT-001-CB

Phase 3

Mobilized

Blood/Bone

Marrow HSCs

ECT-001-mPB
ECT-001-BM

Pre-Clinical

Engineered

HSCs (eHSCs)

ECT-002

Pre-Clinical

Solid organ tolerization

Bone Marrow HSCs

+ collaborators

Pre-Clinical

iPSC

Pluripotent

Stem Cells (PSCs)

Out-licence
& supply

Pre-Clinical

Gene Therapy

Transduced

HSCs

+ collaborators

Phase I